Regenerative Medicine: A Potential Antidote for Chronic Pain
by Hamna Bano
SHARES
Alexios Crayannopoulos, DO, MPH, DABPMR, chief of departments of physical medicine and rehabilitation at Rhode Island Hospital and Newport Hospital, chief of the division of physical medicine and restoration of Lifespan Physician Group, and associate professor at Brown University Warren Alpert Medical School.
The application of regenerative medicine to reduce persistent pain grips great potential and the data bank to support the convention is expanding, he said. Crayannopoulos conducted a session on
“Regenerative Medicine: What has functioned and what about the evidence?” during the regional Anesthesia Society and the twentieth annual medicine to reduce pain meeting that was held in San Francisco.
The promise of regenerative medicine to treat chronic pain https://t.co/qFCbc6fRQF #Neuroscience #Healthcare #Insights
— Andrew @Vital Connections, Medical Market Research (@VitalConnectMRX) September 18, 2021
He said that he would like to have more sessions where he’ll be able to provide “a wider understanding of and recognition for the theory backside regenerative medicine and its auspicious uses in the management of pain. Different researches on stem cell use and other FDA-approved applications on humans make clear that the field is wide open.
Regenerative medicine is the procedure of nonrenewable damaged cells, organs, and tissues. Present animal-derived research is examining the effectiveness of this medicine in treating the pain that comes from osteoarthritis and diabetic neuralgia, among others. There are other researches being done that show the analgesic effects of injecting certain types of stem cells into people with spinal cord injuries and degenerative disc disease. Severe nerve or neuropathic pain, as well as skeletal or nociceptive pain, are also said to be treated completely by the use of regenerative medicine.
Carayannopoulos said, “if confirmed in human studies, the spinal injury findings raise the spirit of being able to use aggressive rehabilitation to treat such injuries.”
Although regenerative medicines are becoming slowly viable, it is a very unregulated industry with a long and expensive road to Drug and Federal Food Administration approvals. Also, these regenerative medications are not part of the insurance most of the time, which makes it tough for the patients to buy them from the market. However, this exercise has such immense consequences in pain management that it can change the game of using medications and their proficiency, and even the length of the life span of a living being.
